News

SME-owners daily rate update for HORIZON

Published on | 7 months ago

Programmes
Horizon Europe HorizonEU L+F

The personnel cost of SME owners and natural persons beneficiaries has to be declared by using the unit cost (daily rate) fixed by the authorisation decision C(2020)7155 and set out in Annex 2a, as explained in the Annotated Model Grant Agreement p 64.

This Annex 2a has been updated again in December, stating the following SME owner unit cost expressed as daily rates:

  • For calls with opening date before 30 July 2024: {EUR 5 080 / 18 days = 282,22} multiplied by{country-specific correction coefficient of the country where the beneficiary is established}
  • For calls with opening date as from 30 July 2024: {EUR 8 745,40 / 18 days = 485,85} multiplied by {country-specific  orrection coefficient of the country where the beneficiary is established}
  • For calls with opening date as from 16 December 2025: {EUR 9271 / 18 days = 515,06} multiplied by {country-specific correction coefficient of the country where the beneficiary is established}

The country-specific correction coefficients used are those set out in the Horizon Europe Work Programme
(section Marie Skłodowska-Curie actions) in force at the time of the call (see Portal Reference Documents). For Belgium this coefficient equals 1.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1981 articles available search in articles 

Testimonial

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.